A Clinician's Perspective on Cancer Drug Development

A Clinician's Perspective on Cancer Drug DevelopmentПодробнее

Cancer-Associated Thrombosis and Antiphospholipid Syndrome: An Update for CliniciansПодробнее

06 -Cancer Drug Development- Interview with Dr. Alex AdjeiПодробнее

Conversations on Cancer: The Future of Childhood Cancer Drug Development: Is the Sky the Limit?Подробнее

Precision medicine: facilitating cancer treatment decisions and drug developmentПодробнее

Conversations On Cancer: A Global Dialogue on Ovarian CancerПодробнее

Conversations on Cancer: Clinical Trial Site Selection: Fact vs FictionПодробнее

Oncology Drug Modalities: A New Era in Oncology Drug DevelopmentПодробнее

Redefining Cancer Drug Development...Подробнее

Advancing Precision Cancer Medicine: Unveiling the Future FrontierПодробнее

Developing Drugs For Cancer ResearchПодробнее

Early drug development: Dr. Geoffrey Shapiro | Dana-Farber Cancer InstituteПодробнее

How MD Anderson’s TRACTION Platform is accelerating drug developmentПодробнее

Novel Strategies for Drug Development in Cancer: An Industry PerspectiveПодробнее

A promising future for drug development in gastrointestinal cancerПодробнее

IASLC Webinar: Cancer Drug Development in the Era of Precision MedicineПодробнее

May 2014 Webinar - Imaging Guided Investigation in Cancer Drug DevelopmentПодробнее

Challenges of drug repurposingПодробнее

A Look at Overall Survival Data in Cancer Clinical TrialsПодробнее

MAP 2023 RoadMAP to the Clinic: Charles Swanton on this new event about future clinical trialsПодробнее

Oncology Drug Development in the Era of Precision Medicine: FDA PerspectiveПодробнее